Immune responses in the intestinal tract differ than in peripheral lymphoid organs, since the immunologic tone of the gutassociated lymphoid tissue is one of suppression rather than of active immunity. Uncontrolled intestinal immune responses may lead to inflammatory bowel diseases. Regulatory T cells have been reported to play a potential role in controlling the balance between protective immunity and tolerance. However, the induction and expansion of regulatory T cells at sites of intestinal inflammation has not yet been fully understood and may involve antigen presentation by local professional and/or non-professional antigen presenting cells. Here we demonstrate that intestinal self-antigen expression leads to peripheral expansion of antigen-specific CD4+Foxp3+ regulatory T cells which is restricted to the mesenteric lymph nodes and the lamina propria and not induced in the thymus. Although gut-associated dendritic cells are able to induce self-antigenspecific CD4+Foxp3+ T cell proliferation, in vivo depletion of dendritic cells did not preclude the proliferation of these cell in vivo. Interestingly, self-antigen presentation by primary intestinal epithelial cells (IECs) with low expression of MHC class II, CD80 and CD86 is also sufficient to expand self-antigen specific CD4+Foxp3+ regulatory T cells. This mechanism is dependent on MHC class II but unlikely to be dependent on TGF-beta and retinoic acid. Thus, antigen-specific IEC -T cell interactions might represent an alternative target for the therapeutic expansion of regulatory T cells to achieve intestinal homeostasis.
OR.2. Intestinal Antigen Display Promotes the Peripheral Induction of Antigen-specific CD8+Foxp3+ T Cells Diana Fleissner, Jan Buer, Astrid Westendorf University Hospital Essen, Essen, Germany Little data exist regarding mechanisms of mucosal T cell reactivity or tolerance against the variety of antigens in the intestine. In contrast to CD4+ regulatory T cells (Treg), the generation and function of immunosuppressive CD8+ T cells is less well defined. To dissect the reactivity of CD8+ T cells against self-antigen in the intestinal mucosa transgenic mice expressing hemagglutinin (HA) in intestinal epithelial cells and bearing a MHC class-I-restricted T cell-receptor specific for HA were used. In this study we demonstrate that expression of self-antigen in intestinal epithelial cells led to peripheral induction of antigen-specific CD8+Foxp3+ T cells that are able to suppress the proliferation of CD8+ and CD4+ T cells in vitro. HA-specific CD8+Foxp3+ T cells revealed a specific expression of CD4+ Treg associated genes. Furthermore, a small fraction of antigen-specific CD8+Foxp3+ T cells was generated by gut-associated dendritic cells in vitro. Interestingly, polyclonal stimulation of naïve CD8+ T cells in the presence of TGF-beta and the vitamin A metabolite retinoic acid induced the differentiation into CD8+Foxp3+ T cells with regulatory function. These results suggest that gutspecific antigen presentation seems to be sufficient to induce CD8+ regulatory T cells presumable supported by TGF-beta and retinoids in the intestinal mucosa. Aim: The role of plasmacytoid DCs (pDCs) in the regulation of intestinal inflammation has not been elucidated. Methods: C57BL/6, CD11c/EYFP, CX3CR1/GFP, Foxp3/GFP and IL-10/ GFP reporter mice were used to determine DC subsets and Treg recruitment and function during acute colitis and mucosal healing. DC subsets were analyzed in the normal colon, during acute colitis after 5 days of DSS and during the recovery from colitis. Confocal microscopy combined with intravital immunostaining was used to define distribution and migration of DC subsets and Tregs in vivo. Results: pDCs became a major DCs subset in the colon lamina propria increasing from 2 ± 2% and 4 ± 3 % in the normal and inflamed colon respectively to 34 ± 12% of CD11c+ F4/80-DCs during mucosal restitution. The percentage of pDCs remained at elevated levels for over 3 weeks after a 5-day application of DSS (16 ± 4% of CD11c+F4/80-DCs). The pDCs recruited during the recovery from colitis were CD11c+CD11b-and co-expressed PDCA-1, Ly6c, Siglec-H, B220 and CD8. FACS sorted colonic pDCs produce IL-10 in response to TLR signals and regulate IL-10 secretion during antigen-specific activation of naïve CD4+ T cells. T cells expressing IL-10 were found to be a subset of Foxp3+ Tregs which emerged in the lamina propria during the recovery from colitis. Depletion of pDCs did not impact the recruitment of Foxp3+ Tregs, but impaired IL-10 secretion by Foxp3+ Tregs and delayed mucosal repair. Conclusion: During colitis, pDCs become a major DC subset in the lamina propria and direct mucosa-specific T cell functions essential for the resolution of inflammation. Our results demonstrate that pDCs display a distinct function in the colon in defining intestine-specific adaptations of T effectors and Foxp3+ Tregs to mucosal inflammation. Background: Evidence for a role of probiotics in the management of allergic diseases is emerging. Objective: To test the immunomodulatory effects of oral versus intranasal administration of L. paracasei NCC2461 in a mouse model of respiratory allergy. Methods: Mice were sensitized intraperitoneally with ovalbumin (OVA) and challenged with OVA aerosols. L. paracasei NCC2461 strain was administered between challenges either intragastrically or intranasally. Airway inflammation, eotaxin and IL-5 production in the lungs and OVA-specific IgE production in sera were measured post-aerosol challenges. Regulatory T cell subsets from lung extracts were evaluated by flow cytometry. Results: Both oral and nasal administrations of L. paracasei NCC2461 efficiently protected sensitized mice against airway inflammation (reduced numbers of eosinophils in bronchoalveolar lavage fluids) upon OVA aerosol challenges, and inhibited OVA-specific IgE production and eotaxin and IL-5 secretion in the lungs, as compared to control mice. Intranasal administration of NCC2461 induced a stronger and more reproducible down-modulation of the allergic response than intragastric application, and increased CD4+CD25+Foxp3+ regulatory T cells in the lungs. Conclusion: L. paracasei NCC2461 administered intranasally or orally display anti-allergic effects in a respiratory allergy mouse model. This effect may be due, at least in part, to the induction of regulatory T cells.
